Replies to post #188503 on Biotech Values

[DewDiligence]

OCRX—a few ammonia-scavenging drugs on the market already, so it was unclear what advantages OCR-002 has? Is it differentiated?

Yes, OCR-002 is differentiated. SLXP’s Xifaxan doesn’t work fast enough in the acute-HE setting, and the SoC laxative (which is a brute-force treatment, not a bona fide ammonia scavenger) is detested by patients and hospital staff.